Girihlet (Seed)
Funding Details
- Date Award
- May 13, 2024
- Vertical
- Diagnostics
- Funding URL
- View Funding Page
Company Info
- Founders
- Ravi Sachidanandam, Anitha Jayaprakash
- Company Description
- Girihlet is a multi-dimensional platform that will accelerate the discovery of disease-monitoring and therapeutic strategies for complex immune diseases. We develop personalized therapeutics for autoimmune disorders by accurately and sensitively profiling immune repertoire profiles, based on proprietary assays and computational algorithms.
- Market
- Human Health
- Location
- United States